Приказ основних података о документу
Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors
dc.creator | Ružić, Dušan | |
dc.creator | Đoković, Nemanja | |
dc.creator | Corentin, Bon | |
dc.creator | Petković, Miloš | |
dc.creator | Ellinger, Bertrand | |
dc.creator | Gul, Sheraz | |
dc.creator | Santibanez, Juan | |
dc.creator | Lahtela-Kakkonen, Maija | |
dc.creator | Halby, Ludovic | |
dc.creator | Ganesan, A. | |
dc.creator | Srdić Rajić, Tatjana | |
dc.creator | Arimondo, Paola | |
dc.creator | Nikolić, Katarina | |
dc.date.accessioned | 2023-07-27T10:35:10Z | |
dc.date.available | 2023-07-27T10:35:10Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4938 | |
dc.language.iso | en | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS// | sr |
dc.rights | restrictedAccess | sr |
dc.source | e-EuCo-CTC 2021, Online conference, EuChemS Division of Computational and Theoretical Chemistry, November 18-19 2021 | sr |
dc.title | Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors | sr |
dc.type | conferenceObject | sr |
dc.rights.license | ARR | sr |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_4938 | |
dc.type.version | publishedVersion | sr |